Servatus Biopharmaceuticals
About:
Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases.
Website: https://www.servatus.com.au
Top Investors: Melbourne Angels
Description:
Servatus is focused on the development of effective treatments for chronic and inflammatory diseases - especially auto-immune diseases - utilising their proprietary technology. They are engineering "intelligent" directed changes into the structure of select proteins to improve their clinical utility.
Total Funding Amount:
7.5M AUD
Headquarters Location:
Sippy Downs, Queensland, Australia
Founded Date:
2012-01-01
Contact Email:
invest(AT)servatus.com.au
Founders:
Wayne Finlayson, Wolf Hanisch
Number of Employees:
1-10
Last Funding Date:
2021-12-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai